The European Equity Fund, Inc. Announces Results of Annual Meeting of Stockholders
Each of the two Class III Directors nominated by the Board of Directors, Dr. Wolfgang Leoni and Mr. Bernhard Koepp, was elected to serve a term of three years and until his successor is elected and qualities. Stockholders also ratified the appointment of Ernst & Young LLP as the independent auditors for the Fund for its 2023 fiscal year. Stockholders did not approve the proposal regarding the ownership threshold required for stockholders to call a special meeting of stockholders.
A copy of the portfolio manager’s presentation from the meeting is posted to the Fund’s website at www.dws.com.
For more information on the Fund, including its most recent month-end performance, visit dws.com or call (800) 349-4281.
For more information on the Fund, including its most recent month-end performance, visit dwsfunds.com or call (800) 349-4281.
Important Information
The Fund is diversified and primarily focuses its investments in equity securities of issuers domiciled in
Closed-end funds, unlike open-end funds, are not continuously offered. There is a one-time public offering and once issued, shares of closed-end funds are sold in the open market through a stock exchange. Shares of closed-end funds frequently trade at a discount to net asset value. The price of the fund’s shares is determined by a number of factors, several of which are beyond the control of the fund. Therefore, the fund cannot predict whether its shares will trade at, below or above net asset value.
War, terrorism, sanctions, economic uncertainty, trade disputes, public health crises and related geopolitical events have led, and, in the future, may lead to significant disruptions in US and world economies and markets, which may lead to increased market volatility and may have significant adverse effects on the funds and their investments.
The European Union,
This press release shall not constitute an offer to sell or a solicitation to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer or solicitation or sale would be unlawful prior to registration or qualification under the laws of such state or jurisdiction.
Certain statements contained in this release may be forward-looking in nature. These include all statements relating to plans, expectations, and other statements that are not historical facts and typically use words like “expect,” “anticipate,” “believe,” “intend,” and similar expressions. Such statements represent management’s current beliefs, based upon information available at the time the statements are made, with regard to the matters addressed. All forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied by, such statements. Management does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. The following factors, among others, could cause actual results to differ materially from forward-looking statements: (i) the effects of adverse changes in market and economic conditions; (ii) legal and regulatory developments; and (iii) other additional risks and uncertainties, including public health crises (including the recent pandemic spread of the novel coronavirus), war, terrorism, trade disputes and related geopolitical events.
Past performance is no guarantee of future results.
NOT FDIC/ NCUA INSURED • MAY LOSE VALUE • NO BANK GUARANTEE
NOT A DEPOSIT • NOT INSURED BY ANY FEDERAL GOVERNMENT AGENCY
The brand DWS represents DWS Group GmbH & Co. KGaA and any of its subsidiaries such as DWS Distributors, Inc. which offers investment products or DWS Investment Management Americas, Inc. and RREEF America L.L.C. which offer advisory services. (R-096489-1) (06/23)
View source version on businesswire.com: https://www.businesswire.com/news/home/20230622006279/en/
For additional information:
DWS Press Office (212) 454-4500
Shareholder Account Information (800) 294-4366
DWS Closed-End Funds (800) 349-4281
Source: DWS